Select your timezone:
Reset
Sat Mar 26 Sun Mar 27 Mon Mar 28 Tue Mar 29

11:00 - 12:00 Networking: Zoom Virtual Hangouts
Zoom room(s) will be open for participants to informally meet each other whether it's for a simply hello or to dive into deeper conversations.

Industry Symposium by Glycorex 07:10 to 07:55

11:10 - 11:55 Industry Symposium: Immunoadsorption for ABO-incompatible Heart Transplantation
Richard Issitt, United Kingdom
Intraoperative anti-A/B immunoadsorption for ABO-incompatible transplantation

Glycorex Industry Symposium

Plenary Session - 08:00 to 09:55

12:00 - 13:55 Plenary: Viral Infections: Consensus, prevention and treatment
George V. Mazariegos, United States
Introduction of the Day
Deirdre Hahn, Australia
Patient Voices Recording / Interviewers: Deirdre Hahn / Patient: Madeleine Dominello
Upton Dilworth Allen, Canada
EBV/PTLD IPTA consensus conference: Where are we now?
Klara M Posfay-Barbe, Switzerland
An ounce of prevention is worth a pound of cure: Update on LIVE viral vaccines after transplantation
Michael S. Grimley, United States
Beyond antivirals: Adoptive T cells for viral infection after transplantation

Oral Abstracts Sessions - 10:00 to 11:10

14:00 - 15:10 Oral Abstracts Session: Liver Clinical - Part 2
Ivone E Malla, Argentina
Liver Transplant with Monosegment in Small Infants
Małgorzata Markiewicz-Kijewska, Poland
Assessment of functional and pathomorphological status of the liver graft in young adults at time of transfer to adult care
Catherine Patterson, Canada
Clinical factors impacting physical function in older children one year post liver transplant
Dor Yoeli, United States
Immediate extubation following pediatric liver transplantation
Dor Yoeli, United States
The Pediatric Liver Transplant Donor Risk Index (PLT-DRI)
Noelle H Ebel, United States
Towards identifying predictors of pediatric heart only versus combined heart liver transplantation
14:00 - 15:10 Oral Abstracts Session: Kidney Biomarkers
Raja Dandamudi, United States
Longitudinal studies of blood donor-derived cell free DNA (dd-cfDNA) show predictable rise at time of BK viremia or viruria in Pediatric Kidney Transplant Recipients (PKTx).
Charlotte Duneton, France
Evaluation of the significance of isolated C4d staining without histological evidence of rejection on kidney biopsies after ABO-compatible transplantation in pediatric recipients
Vaka K Sigurjonsdottir, United States
Complement-Binding Donor Specific Anti-HLA Antibodies: Biomarker for Immunologic Risk Stratification in Pediatric Kidney Transplantation Recipients
Gwenaelle Roussey, France
Epitopic mismatch and risk of developing DSA in pediatric kidney transplantation
Dechu Puliyanda, United States
Use of donor-derived cell-free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection
Maiya Rasheed, Canada
Eplet mismatching and subclinical inflammation in a pediatric kidney transplant population
14:00 - 15:10 Oral Abstracts Session: Covid - Part 2
Yash Kadakia, United States
Pediatric Donation During COVID-19 Pandemic
Marco Cazzaniga, Italy
Seroprevalence of SARS-CoV-2 antibodies in a kidney transplant pediatric recipients cohort from a single Center in Northern Italy
Caroline X Qin, United States
Humoral Response to BNT162b2 SARS-CoV-2 Vaccination in Pediatric Solid Organ Transplant Recipients
Helen Pizzo, United States
SARS-CoV-2 Antibody and T cell Response After Vaccination With or Without Intensified Immunosuppression Among Pediatric Transplant Recipients
Nancy Halnon, United States
Allosensitization and development of de-novo DSA are not frequent after infection with SARS-CoV-2 and COVID-19.
Esra Baskin, Turkey
How Dangerous Is Covid-19 Infection in Pediatric Kidney Transplant Recipients? - A Single-Center Experience

Interactive Workshops - 11:15 to 12:15

15:15 - 16:15 Workshop: New Technologies for Individualized Patient Management
Massimo Mangiola, United States
Improve assessment of compatibility in solid organ transplantation
Johannes Wedel, United States
Transcriptomics and Machine Learning as Tools to Guide Clinical Decisions
Philip J O'Connell, Australia
Molecular profiling and stratification of transplants
15:15 - 16:15 Workshop: IPTA-PHTS Session on Ethical Quandaries in Pediatric Thoracic Transplantation
vernat Exil, United States
Who Gets Listed? A Discussion of Controversies in Listing Decisions
Jacob Simmonds, United Kingdom
An Update on DCD Donation in Pediatric Thoracic Transplantation
Chesney Castleberry, United States
Who Gets a VAD? Ethical Dilemmas in VAD Decision-Making

Session Supported by

15:15 - 16:15 Workshop: IPTA-ASTS Session on Pediatric Surgery Challenging Cases
C. Andrew Bonham, United States
Case 1: Technical Challenges of low portal vein flow in pediatric Liver Transplantation
Amy Gallo, United States
Case 2: Infant kidney with IVC thrombosis, vascular anastomosis: how to choose the site for vascular anastomosis
Dominique M Jan, United States
Case 3: Management of Hepatic artery thrombosis

Session Supported by

State-of-the-Art Session - 12:20 to 12:50

16:20 - 16:50 State-of-the-Art Session: Organ Bioengineering- Lessons from the intestine
David J. Hackam, United States
Organ Bioengineering - Lessons from the intestine
16:55 - 17:00 Live Virtual Stretching Break

Break Supported by

Oral Abstracts Sessions - 13:00 to 14:10

17:00 - 18:10 Oral Abstracts Session: Kidney Clinical - Part 2
Rachel Engen, United States
Outcomes of granulocyte colony-stimulating factor use in pediatric kidney transplant recipients: a Pediatric Nephrology Research Consortium study
Daniella Levy Erez, Israel
Clinical outcomes associated with with induction regimens for kidney transplantation among children: a NAPRTCS and PHIS collaborative study
Christian Patry, Germany
Pre- vs. posttransplant operative reconstruction of the lower urinary tract in pediatric kidney transplant recipients: a CERTAIN multicenter analysis
Christian Patry, Germany
Publication rate and research topics of studies in pediatric kidney transplantation
Samhar Al-Akash, United States
Re-transplantation in Pediatric Patients with Failure of Primary Transplant due to Recurrent Focal Segmental Glomerulosclerosis. A Pediatric Nephrology Research Consortium Study.
Lars Pape, Germany
Health Care Transition of Adolescents After Kidney Transplantation in Germany and Austria – The Randomized Controlled TRANSNephro Trial
17:00 - 18:10 Oral Abstracts Session: Thoracic
Aine Lynch, Canada
Relationship between timing and duration of systemic ventricular dysfunction in Hypoplastic Left Heart Syndrome and transplant-free survival
David M Newland, United States
Comparison of metabolic adverse effects of sirolimus and everolimus in pediatric heart transplant recipients
David M Newland, United States
Comparison of adverse effects of sirolimus versus everolimus in pediatric heart transplant recipients
Massimo Mangiola, United States
Improved Immunological Risk Stratification of Pediatric Heart Transplant Patients by Combining PIRCHE-II with HLAMatchmaker or HLA-EMMA.
Barbara Cardoso, United Kingdom
Eplet Matching in Pediatric Heart Transplantation: the SickKids experience
Louise Bannister, Canada
Tube assisted feeding and the transition to oral feeding in infants post-heart transplant
17:00 - 18:10 Oral Abstracts Session: Donation
Stefany Hernandez Benabe, United States
Current international deceased donation solid organ transplantation allocation practices for pediatric recipients
Yash Kadakia, United States
Expanding the Utilization of Pediatric DCD Donors - A Role for Normothermic Machine Perfusion?
Zainab Arslan, United Kingdom
Kidney Transplantation from Donors with Vaccine Induced Thrombocytopenia and Thrombosis
Megan A Adams, United States
Living Donor Liver Transplant Center Volume Influences Waiting List Survival Among Children Listed for Liver Transplantation
Rachel Engen, United States
Impact of multiorgan and kidney-pancreas allocation policies on pediatric kidney-alone transplant candidates in the United States

Plenary Session - 14:15 to 15:45

18:15 - 19:45 Plenary: Organ Allocation Around the World: How do we prioritize children?
Ronalda De Lacy, South Africa
Patient Voices Recording / Interviewer: Ronalda De Lacy / Patient: Oluphelo Jebe
Lainie F Ross, United States
Utility vs. equity in organ allocation
Alicia Pérez Blanco, Spain
Perspective from Spain
Evelyn K. Hsu, United States
Perspective from North America
Helen M. Evans, New Zealand
Perspective from Oceania
Joao Seda Neto, Brazil
Perspective from South America

SOTA Session, IPTA Awards and Closing Remarks - 15:50 to 17:00

19:50 - 20:20 State-of-the-Art Session: Analytics and Augmented Intelligence in Transplant
Alexandre Loupy, France
Analytics and augmented intelligence in transplant
20:20 - 21:00 Plenary: IPTA Awards and Closing Remarks
Mignon I McCulloch, South Africa
Acknowledgments from Congress Chair
Anne Dipchand, Canada
Awards Presentations
Ron Shapiro, United States
Lifetime Achievement Award
Louise Bannister, Canada
Distinguished Allied Health and Nursing Professional Award
Noelle H Ebel, United States
Future Leaders Career Development Award
Aine Lynch, Canada
Future Leaders Career Development Award
Carlos O. Esquivel, United States
Closing Remarks and Welcome to IPTA 2023 Austin
21:00 - 21:30 Networking: Zoom Virtual Hangouts
Zoom room(s) will be open for participants to informally meet each other whether it's for a simply hello or to dive into deeper conversations.